Chronic Lymphocytic Leukemia

Chronic Lymphocytic Leukemia is the indication for 16 drugs in DrugBank. It is covered by 27 curated, structured indications.

Also known as: CLL · Chronic Lymphocytic Leukemia (CLL) · Chronic Lymphocytic Leukaemia · Chronic Lymphoid Leukemia · Chronic Lymphocytic Leukemias
Classified under: Hemic and Lymphatic Diseases
Immune System Diseases
Neoplasms
Indicated drugs: Acalabrutinib
Alemtuzumab
Chlorambucil
Cladribine
Cyclophosphamide
Hyaluronidase (ovine)
Ibrutinib
Mechlorethamine
Obinutuzumab
Ofatumumab
Pentostatin
Pirtobrutinib
Rituximab
Venetoclax
Vincristine
Zanubrutinib

Resolves to

Vocabularies

MeSHT687709ICD-10C91.1SNOMED CT154589005MedDRA10024295UMLSC0023434

What you can answer from here — as of October 17, 2026

16Indicated drugsWith each drug's targets and mechanism

Listed above

27Structured indicationsPopulation, line of therapy, route and combination as fields, not prose

984Clinical trialsPhase, status and sponsor resolved per trial

1Contraindicated drugDrugs whose labels contraindicate them in this condition

8Drugs reporting it as an adverse effectWith incidence where the label states it

Which approved drugs for Chronic Lymphocytic Leukemia share a target, and which companies have late-stage candidates against it?

Create a free account or log in to explore the full data card.